Legendary Grateful Dead founder and guitarist Bob Weir announced this week that due to popular demand they will be including an additional 3 shows in the upcoming Wolf Bros Tour. Major cities Chicago, Boston and New York will be seeing multiple performances at iconic venues like the Chicago, Wang and Beacon Theatres.
In what is expected to be a stellar and electrifying tour, the band will be revisiting several Grateful Dead classics in their lineup of songs that Weir has excitedly described will be played in a “trio setting.” Although this is the group’s first formal tour, the chemistry between members is undeniable as both Weir and veteran drummer Jay Lane collaborated in the American Jazz band RatDog. Not to mention the contributions on bass guitar from the successful musician, producer, and president of Blue Note Records, Don Was. This culmination of different sounds from each of these widely respected musicians has earned this tour tremendous popularity and will certainly be a beautiful rekindling and demonstration of the legacy of Grateful Dead music.
See tour dates below:
October 16 Reno, NV—Grand Sierra Resort and Casino
October 18 Los Angeles, CA—The Theatre at Ace Hotel
October 20 Santa Barbara, CA—Arlington Theatre
October 22 Portland, OR—Keller Auditorium
October 23 Seattle, WA—Moore Theatre
October 24 Missoula, MT—Wilma Theatre
October 26 Salt Lake City, UT—Eccles Theater
October 27 Albuquerque, NM—Kiva Auditorium
October 29 Denver, CO—Paramount Theatre
October 31 Chicago, IL—Chicago Theatre
November 1 Chicago, IL—Chicago Theatre
November 5 Nashville, TN—Ryman Auditorium
November 6 Louisville, KY—Palace Theatre
November 8 Syracuse, NY—Landmark Theatre
November 9 Port Chester, NY—The Capitol Theatre
November 10 Port Chester, NY—The Capitol Theatre
November 12 Washington, DC—Warner Theatre
November 13 Philadelphia, PA—The Fillmore
November 15 Boston, MA—Boch Center Wang Theatre
November 16 Boston, MA—Boch Center Wang Theatre
November 18 New York, NY—Beacon Theatre
November 19 New York, NY—Beacon Theatre
Comments are closed.